4
Neuralink Corp., Elon Musk’s brain implant company, has submitted a scientific paper to a journal describing the results from some of its patients, which would be its first peer-reviewed publication with human data.
The paper was sent to the New England Journal of Medicine and describes the first three patients who were implanted with the Neuralink device, including safety data, according to Michael Lawton, chief executive officer and president of the Barrow Neurological Institute, a Neuralink clinical trial site.
Neuralink is one of several…
